Impax Laboratories Inc. (IPXL) reported first quarter adjusted EPS of $0.09 after the bell Monday, down from $0.24 in the prior year period. Analysts expected EPS of $0.18. The stock is now down 3.84 on 49K shares.
Impax Laboratories climbed throughout the first half of Monday's session and finished with a gain of 0.99 at $46.10. The stock closed near the upper end of a week and a half long trading range.
For comments and feedback contact: editorial@rttnews.com
Business News